Shohei Ohtani, the Los Angeles Angels’ two-way star, will continue to play in the team’s lineup and take his turn at bat despite suffering a torn ulnar collateral ligament (UCL) in his throwing arm. This revelation comes after an MRI confirmed the tear but showed no immediate need for surgery. Ohtani will be sidelined from pitching for the remainder of the season, but he plans to contribute as a designated hitter.
Ohtani’s condition became apparent when he experienced arm fatigue in his recent start, leading to an early exit from the game. Manager Phil Nevin revealed that the fatigue was similar to what caused Ohtani to skip his previous start. Although the tear in his UCL raises questions about his ability to return to the mound at full strength, he remains committed to being a presence in the Angels’ lineup.
This isn’t the first time Ohtani has dealt with a UCL tear. Back in 2018, he managed to continue as a designated hitter despite undergoing Tommy John surgery after the season concluded. However, the stakes are higher this time. The impending free agency of the Japanese sensation means that any surgical intervention could impact his market value, potentially affecting the size of the contract he receives. Analysts are questioning whether a second Tommy John surgery could impede Ohtani’s effectiveness as a pitcher.
In light of these circumstances, Ohtani is carefully considering his options and seeking a second opinion before making a decision regarding surgery. The outcome of this evaluation will determine the best course of action for his future.
Fans and analysts alike eagerly await Ohtani’s decision and hope for a quick and successful recovery. In the meantime, the focus will shift to his performance as a hitter and the impact he can continue to make from within the Angels’ lineup. As this story unfolds, the baseball world remains captivated by the extraordinary talent of Shohei Ohtani.
